The Effects of Sirolimus in Patients With Dilated Cardiomyopathy Infected With Kaposi Sarcoma-associated Virus
Recruiting now · Phase 4
Conditions studied: Dilated Cardiomyopathy, Kaposi's Sarcoma-Associated Herpesvirus Infection
In brief
Evaluating the efficacy of sirolimus (compared to standard therapy alone) in the treatment of dilated cardiomyopathy infected with Kaposi Sarcoma-associated virus -- a multicenter randomized controlled study.
Key facts
- Study ID
- NCT06236022
- Run by
- Tongji Hospital
- People needed
- 276
- Starts
- 2024-01-01
- Expected to finish
- 2028-12-31
- Last updated by the study team
- 2024-02-01
Who can join
Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- 18 to 70 years of age;
- Diagnosed as dilated cardiomyopathy. Specifically, (i) left ventricular ejection fraction <45% (>2 SD) and/or fractional shortening <25% (>2 SD), as ascertained by echocardiography, radionuclide scanning, or cardiac magnetic resonance imaging; (ii) left ventricular end-diastolic diameter >117% of the predicted value corrected for age and body surface area (Henry's formula), which corresponds to 2 SD of the predicted normal limit +5%; and (iii) In the absence of severe coronary artery disease or valvular disease.
- KSHV DNA seropositivity;
- Patients are voluntary and signed informed consent.
You may not qualify if…
- Allergic to rapamycin or its derivatives;
- The proportion of neutrophils less than 0.5*10\^9/L or platelet less than 2.5*10\^10/L;
- Pregnant women or plan to;
- Participate in any drug clinical trials within 3 months;
- Serious neurological disease (Alzheimer's disease, Parkinson syndrome, progressive lower limbs or deaf patients);
- Previous history of cancer or tumor, or pathological examination confirmed precancerous lesions;
- Patients were not optimally managed.
Where it is running
- Tongji Hospital — Wuhan, Hubei, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.